Suppr超能文献

TAT-14-3-3ε融合蛋白对大鼠脑缺血/再灌注损伤的神经保护作用

Neuroprotective effect of TAT-14-3-3ε fusion protein against cerebral ischemia/reperfusion injury in rats.

作者信息

Zhu Yuanjun, Bu Qixin, Liu Xiaoyan, Hu Wenhui, Wang Yinye

机构信息

Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing, China.

Department of Neuroscience, Temple University School of Medicine, Philadelphia, Pennsylvania, United States of America.

出版信息

PLoS One. 2014 Mar 26;9(3):e93334. doi: 10.1371/journal.pone.0093334. eCollection 2014.

Abstract

Stroke is the major cause of death and disability worldwide, and the thrombolytic therapy currently available was unsatisfactory. 14-3-3ε is a well characterized member of 14-3-3 family, and has been reported to protect neurons against apoptosis in cerebral ischemia. However, it cannot transverse blood brain barrier (BBB) due to its large size. A protein transduction domain (PTD) of HIV TAT protein, is capable of delivering a large variety of proteins into the brain. In this study, we generated a fusion protein TAT-14-3-3ε, and evaluated its potential neuroprotective effect in rat focal ischemia/reperfusion (I/R) model. Western blot analysis validated the efficient transduction of TAT-14-3-3ε fusion protein into brain via a route of intravenous injection. TAT-14-3-3ε pre-treatment 2 h before ischemia significantly reduced cerebral infarction volume and improved neurologic score, while post-treatment 2 h after ischemia was less effective. Importantly, pre- or post-ischemic treatment with TAT-14-3-3ε significantly increased the number of surviving neurons as determined by Nissl staining, and attenuated I/R-induced neuronal apoptosis as showed by the decrease in apoptotic cell numbers and the inhibition of caspase-3 activity. Moreover, the introduction of 14-3-3ε into brain by TAT-mediated delivering reduced the formation of autophagosome, attenuated LC3B-II upregulation and reversed p62 downregulation induced by ischemic injury. Such inhibition of autophagy was reversed by treatment with an autophagy inducer rapamycin (RAP), which also attenuated the neuroprotective effect of TAT-14-3-3ε. Conversely, autophagy inhibitor 3-methyladenine (3-MA) inhibited I/R-induced the increase in autophagic activity, and attenuated I/R-induced brain infarct. These results suggest that TAT-14-3-3ε can be efficiently transduced into brain and exert significantly protective effect against brain ischemic injury through inhibiting neuronal apoptosis and autophagic activation.

摘要

中风是全球范围内导致死亡和残疾的主要原因,而目前可用的溶栓疗法并不理想。14-3-3ε是14-3-3家族中一个特征明确的成员,据报道它能保护神经元免受脑缺血诱导的细胞凋亡。然而,由于其分子量大,它无法穿过血脑屏障(BBB)。HIV TAT蛋白的蛋白转导结构域(PTD)能够将多种蛋白质递送至脑内。在本研究中,我们构建了融合蛋白TAT-14-3-3ε,并在大鼠局灶性缺血/再灌注(I/R)模型中评估了其潜在的神经保护作用。蛋白质印迹分析证实TAT-14-3-3ε融合蛋白可通过静脉注射途径有效地转导至脑内。在缺血前2小时进行TAT-14-3-3ε预处理可显著减小脑梗死体积并改善神经功能评分,而在缺血后2小时进行治疗则效果较差。重要的是,通过尼氏染色确定,缺血前后用TAT-14-3-3ε治疗均显著增加了存活神经元的数量,并如凋亡细胞数量减少和半胱天冬酶-3活性受到抑制所示,减轻了I/R诱导的神经元凋亡。此外,通过TAT介导递送将14-3-3ε引入脑内减少了自噬体的形成,减轻了LC3B-II的上调,并逆转了缺血损伤诱导的p62下调。用自噬诱导剂雷帕霉素(RAP)处理可逆转这种自噬抑制,这也减弱了TAT-14-3-3ε的神经保护作用。相反,自噬抑制剂3-甲基腺嘌呤(3-MA)抑制了I/R诱导的自噬活性增加,并减轻了I/R诱导的脑梗死。这些结果表明,TAT-14-3-3ε可有效地转导至脑内,并通过抑制神经元凋亡和自噬激活对脑缺血损伤发挥显著的保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf0c/3966873/57b9ca9bea8d/pone.0093334.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验